Literature DB >> 30242811

How Should Primary Care Physicians Respond to Direct-to-Consumer Genetic Test Results?

Kyle B Brothers1, Esther E Knapp2.   

Abstract

In this case, a primary care physician is presented with direct-to-consumer genetic test results and asked to provide counseling and order follow-up diagnostics. In order to deal effectively with this situation, we suggest physicians need look no further than the practice principles that guide more routine clinical encounters. We examine the rationale behind 2 major clinical ethical considerations: (1) physicians have obligations to help their patients achieve reasonable health goals but are not obligated to perform procedures that are not medically indicated; and (2) primary care physicians do not need to know everything; they just need to know how to get their patients appropriate care.
© 2018 American Medical Association. All Rights Reserved.

Entities:  

Year:  2018        PMID: 30242811     DOI: 10.1001/amajethics.2018.812

Source DB:  PubMed          Journal:  AMA J Ethics


  4 in total

1.  Consistency of Direct-to-Consumer Genetic Testing Results Among Identical Twins.

Authors:  Anne M Huml; Catherine Sullivan; Maria Figueroa; Karen Scott; Ashwini R Sehgal
Journal:  Am J Med       Date:  2019-06-15       Impact factor: 4.965

Review 2.  Cases in Precision Medicine: Concerns About Privacy and Discrimination After Genomic Sequencing.

Authors:  Deborah Stiles; Paul S Appelbaum
Journal:  Ann Intern Med       Date:  2019-05-07       Impact factor: 25.391

3.  Pilot study of an Alzheimer's disease risk assessment program in a primary care setting.

Authors:  Laura E Korthauer; Charles Denby; David Molina; Janet Wanjiku; Lori A Daiello; Jonathan D Drake; Josh D Grill; Brian R Ott
Journal:  Alzheimers Dement (Amst)       Date:  2021-02-20

4.  Health and kinship matter: Learning about direct-to-consumer genetic testing user experiences via online discussions.

Authors:  Zhijun Yin; Lijun Song; Ellen W Clayton; Bradley A Malin
Journal:  PLoS One       Date:  2020-09-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.